DISCOVERY COLLABORATION AND LICENSE AGREEMENTDiscovery Collaboration and License Agreement • May 9th, 2019 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances)
This First Amendment (the “First Amendment”) to the Discovery Collaboration and License Agreement dated October 10, 2017 (the “Agreement”) by and between Harpoon Therapeutics, Inc., a Delaware corporation (“Licensor”), and AbbVie Biotechnology Ltd., a Bermuda corporation (“AbbVie”) is made effective as of the date of the final signature to this First Amendment. Licensor and AbbVie are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
